Clostridium butyricum and Reduced Helicobacter Pylori Infection

• The efficacy and safety of Clostridium butyricum and Bacillus coagulans in Helicobacter pylori eradication treatment: An open-label, single-arm pilot study.

  • 2020-11-06
  • RCT · n = 150
  • Medicine 99(45)
  • • Jian Zhang
    • Jingzhi Guo
    • Dan Li
    • Min Chen
    • Jie Liu
    • Chenchen Feng
    • Qi He
    • Jing Zhao
    • Luyao Zhang
    • Jie Chen
    • Yongquan Shi

  • PubMed: 33157939
  • DOI: 10.1097/md.0000000000022976

  2 Insights on

  • Reduced Helicobacter Pylori Infection

  • High evidence
  • Large Human Trial
  • Clinical

  The ITT analysis demonstrated that the 3 groups achieved similar eradication rates (18%, 20%, and 26%, respectively, P = .597).

  Effect

  Neutral

  Effect size

  Small

  Significant

  No

  Dose

  not stated